Journals / Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi / 2019 / Cilt: 6 - Sayı: 3

The Effect of Prognostic Criteria on the Early Radiological Response After Radiotherapy in Cervical Cancer

Serviks Kanserinde Prognostik Kriterlerin Tedavi Sonrası Erken Radyolojik Cevaba Etkisi

Pages
154–159
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Some of the known prognostic criteria in cervical cancer may be associated with early term tumor response to treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to determine the relationship between known prognostic factors and early radiological tumor response in patients with cervical cancer.Methods: In our clinic, magnetic resonance (MR) and positron emission tomography-computed tomography (PET-CT) were performed before and after external pelvic radiotherapy and brachytherapy to 26 patients who performed definitive radiotherapy and concurrent chemotherapy.
📊
Key Findings & Data:The relationship of radiological clinical response / tumor response with prognostic criteria was evaluated retrospectively.Results: When the measurement percentage differences between tumor diameter and SUVmax value were compared in pre- and post-treatment MR and PET-CT tests; there was a statistically significant correlation between the presence of cigarette smoking (p = 0.07) and initial tumor diameter over 2 cm (p = 0.01) in patients with MR responses are under 50%.
💡
Conclusion & Impact:Conclusion: Some of the known prognostic criteria in cervical cancer may be associated with early term tumor response to treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:serviks kanseri · prognostik krterler · radyolojik cevap

Abstract

Objective: The aim of this study was to determine the relationship between known prognostic factors and early radiological tumor response in patients with cervical cancer.Methods: In our clinic, magnetic resonance (MR) and positron emission tomography-computed tomography (PET-CT) were performed before and after external pelvic radiotherapy and brachytherapy to 26 patients who performed definitive radiotherapy and concurrent chemotherapy. The relationship of radiological clinical response / tumor response with prognostic criteria was evaluated retrospectively.Results: When the measurement percentage differences between tumor diameter and SUVmax value were compared in pre- and post-treatment MR and PET-CT tests; there was a statistically significant correlation between the presence of cigarette smoking (p = 0.07) and initial tumor diameter over 2 cm (p = 0.01) in patients with MR responses are under 50%. In PET-CT, there was a statistically significant relationship in patients with SUVmax change rate less than 50%, in terms of squamous cell carcinoma histology (p = 0.03) and bladder invasion (p = 0.06). Conclusion: Some of the known prognostic criteria in cervical cancer may be associated with early term tumor response to treatment.

Özet

Amaç: Serviks kanseri tanısıyla kliniğimizde tedavi uygulanan hastalarda bilinen prognostik faktörlerin, erken dönem radyolojik tümör yanıtı ile olan ilişkisini belirlemek amaçlandı. Gereç-Yöntem: Kliniğimizde definitif radyoterapi ve eş zamanlı kemoterapi uygulanan 26 hastanın eksternal pelvik radyoterapi ve brakiterapi öncesi ve sonrasında çekilen manyetik rezonans (MR) ve pozitron emisyon tomografisi-bilgisayarlı tomografi (PET-CT) tetkikleri ile gözlenen radyolojik klinik cevabın/tümör yanıtının prognostik kriterler ile ilişkisi retrospektif olarak değerlendirildi. Bulgular: Tedavi öncesi ve sonrası MR ve PET-CT tetkiklerindeki tümör çapı ve SUVmax değeri ölçüm yüzde farkları karşılaştırıldığında; MR’da % 50’nin altında yanıt alınanlarda sigara varlığı (p=0,07) ve başlangıç tümör çapının 2 cm’nin üzerinde olması (p=0,01) ile istatistiksel anlamlı ilişki mevcuttu. PET-CT’de ise SUVmax değişim oranı % 50’nin altında yanıtlı hastalarda skuamoz hücreli karsinom dışı histoloji (p=0,03) ve mesane invazyonu varlığı (p=0,06) açısından istatistiksel açıdan anlamlı bir ilişki saptandı. Sonuç: Serviks kanserinde bilinen prognostik kriterlerden bazıları tedaviye bağlı erken dönem tümör cevabı ile ilişkili olabilir.

🔖

Cite This Article

ŞEN, C. A. (2019). The Effect of Prognostic Criteria on the Early Radiological Response After Radiotherapy in Cervical Cancer. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, Cilt: 6 - Sayı: 3, 154–159. https://ajindex.com/articles/146316

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. American Cancer Society 2018,
  2. Uterine cervix, Cancer Facts & Figures 2018, page 25 2. Kurtoğlu E, AG Ayşenur. Cervical cancer epidemiology, Turkiye Klinikleri J Gynecol Obst-Special Topics 2014;7(4):1-4 3. Parkin DM, Bray F, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108. 4. National Comprehensive Cancer Network, Clinical Practice Guidelines in Oncology, Version 2. 2019, October 12. 2018, Cervical Cancer, https://www.nccn.org, Erişim tarihi: 12.11.2018 5. Viani GA, Manta GB, et al. Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy - a meta-analysis of clinical trials. J Exp Clin Cancer Res. 2009 Apr 5;28:47 6. Endo D, Todo Y, et al. Prognostic factors for patients with cervical cancer treated with concurrent chemoradiotherapy: a retrospective analysis in a Japanese cohort. J Gynecol Oncol. 2015 Jan;26(1):12-18 7. Wang SC, Lin LC, et al. Radiographic number of positive pelvic lymph nodes as a prognostic factor in cervical cancer treated with definitive concurrent chemoradiotherapy or intensity-modulated radiotherapy. Front Oncol.2018 Nov 30;8:546 8. Asher D, Padgett KR, et al. Magnetic Resonance-guided External Beam Radiation and Brachytherapy for a Patient with Intact Cervical Cancer. Cureus. 2018 May 4;10(5) 9. Balleyguier C, Sala E, et al. Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology. Eur Radiol 2001;21:1102–1110 10. Siegel CL, Andreotti RF, et al. ACR appropriateness criteria(R) pretreatment planning of invasive cancer of the cervix. J Am Coll Radiol 2012;9:395–402 11. Vincens E, Balleyguier C, et al. Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy: correlation of radiologic findings with surgicopathologic results. Cancer 2008;113:2158–2165 12. Sala E, Rockall AG, et al. The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. Radiology 2013;266:717-740 13. Balleyguier C, Sala E, et al. Staging of uterine cervical cancer with MRI: Guidelines of the European Society of Urogenital Radiology. Eur Radiol 2011;21:1102-1110 14. Sala E, Micco M, et al. Complementary prognostic value of pelvic MRI and whole-body FDG PET/CT in the pretreatment assessment of patients with cervical cancer. Int J Gynecol Oncol 2015;25:1461-1467 15. WHO handbook for reporting results of